Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Executive Changes at LifeScience Alley

admin-ajax-115x75

After ten years at helm, Dale Wahlstrom has announced his retirement from LifeScience Alley and The BioBusiness Alliance of Minnesota. Executive Vice President and Chief Operating Officer Shaye Mandle has been selected to lead the organization as president and CEO effective May 1. BIO is grateful to Dale for his strong and insightful leadership over the past 10 years. He has been instrumental to the growth of Minnesota’s life sciences industry and has elevated his Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

PA Bio Names State Official of the Year

admin-ajax (1)

Pennsylvania State Representative Warren Kampf was selected as the recipient Pennsylvania Bio’s 2013 State Official of the Year Award. Representative Kampf will be honored at Pennsylvania Bio’s Annual Dinner and Awards Celebration on March 12th at the Pennsylvania Convention Center in Philadelphia.  The State Official of the Year recognizes a public official from the Commonwealth of Pennsylvania who has distinguished him/herself as a leader in the bioscience industry. The honoree is selected by the Pennsylvania Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BioNJ Streamlines Clinical Trials Agreement Process

bionj3

Biotechnology companies face monumental challenges – from containing R&D costs to managing sales and marketing to compliance with regulatory bodies. Biotech startups often operate with just a few employees, all of whom tend to pull double duty, both in the lab and front office. With that in mind, BioNJ has produced a free document available to companies (not just New Jersey-based ) interested in streamlining the often time-consuming process of negotiating clinical trial agreements. The Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Biotechnology Mending Broken Hearts

Biotech-stem-cell-hearts

It’s been just over 15 years since James Thomson first isolated embryonic stem cells in his lab at the University of Wisconsin-Madison. In that time, some remarkable advances have been made. Namely, I’m talking about the ability to transform adult human cells into extremely useful pluripotent stem cells. A new treatment using pluripotent cells could potentially repair and regenerate damaged heart tissue. In a 2013 study published in The Lancet, Dr. Eduardo Marban, director of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

A New Addition to Pennsylvania Bio’s Leadership Team

ct-115x76

To effectively achieve our mission as the champion and advocate of biotechnology, BIO works with a broad network of organizations. Foremost among these relationships are the ones we possess with a broad network of state-based organizations known as the Council of State Bioscience Associations (CSBA). Pennsylvania Bio (PA Bio) has been a key ally to BIO and vocal advocate for state and federal public policy in support of the biotechnology industry since our inception. Just Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,